Kaiser Permanente Ventures
Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Business Model:
Revenue: $15M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Kaiser Permanente Ventures Information
Geographic Data
Address: 1 Kaiser Plaza
City: Oakland
State: CA
Zip: 94612
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$141M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. Kaiser Permanente Ventures invests predominantly in HCIT and services, as well as diagnostics, drug delivery and therapeutic medical devices.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2005 | NextWeb | Series E | 3.5M |
| 8/2019 | Protenus | Series C | 0 |
| 4/2013 | Nordic | Venture Round | 5M |
| 6/2016 | Kit Check | Series C | 0 |
| 4/2013 | iRhythm Technologies | Series D | 16M |
| 1/2012 | iRhythm Technologies | Private Equity Round | 12.2M |
| 4/2014 | Vapotherm | Series B | 0 |
| 8/2005 | Adiana | Series D | 23M |
| 9/2010 | Accumetrics | Venture Round | 0 |
| 6/2004 | Proteus Digital Health | Series B | 6.3M |
| 1/2020 | Vesta Healthcare | Series A | 30M |
| 6/2013 | Movable | Seed | 1.9M |
| 10/2009 | Accumetrics | Series E | 0 |
| 1/2012 | Transcend Medical | Series B | 16M |
| 7/2016 | Big Health | Series B | 0 |
| 11/2022 | Validic | Venture Round | 12M |
| 12/2014 | Ginger | Series B | 20M |
| 4/2013 | AtheroMed | Private Equity Round | 6M |
| 12/2004 | Radianse | Venture Round | 2M |
| 2/2016 | CareGuardian | Series B | 5M |
| 6/2012 | Oxford Immunotec | Equity | 28M |
| 11/2020 | Kate Farms | Series B | 51M |
| 1/2015 | Ingenious Med | Venture Round | - |
| 11/2011 | Xanitos | Venture Round | 0 |
| 1/2018 | Genome Medical | Series A | 11M |
| 6/2011 | Transcend Medical | Series B | 51M |
| 4/2014 | Transcend Medical | Series C | 0 |
| 7/2016 | Torax Medical | Series E | 0 |
| 11/2003 | NeoGuide Systems | Series B | 0 |
| 2/2019 | Health Catalyst | Series F | 0 |
| 11/2001 | NextWeb | Series C | - |
| 4/2014 | Omada Health | Series B | 23M |
| 3/2012 | AtheroMed | Series D | 4.5M |
| 9/2009 | ValenTx | Series B | 0 |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 9/2011 | Valeritas | Series C | 150M |
| 7/2021 | Osso VR | Series B | 0 |
| 4/2007 | Bacchus Vascular | Venture Round | 6.5M |
| 8/2020 | Freenome | Series C | 270M |
| 8/2022 | Everytable | Series C | 0 |
| 10/2008 | Predictive Biosciences | Series B | 21.8M |
| 4/2010 | Hemosphere | Series A | 9.3M |
| 4/2022 | IntelyCare | Series C | 0 |
| 9/2016 | Chrono Therapeutics | Series B | 47.6M |
| 8/2009 | Silverlink Communications | Series D | 5M |
| 1/2022 | Big Health | Series C | 0 |
| 7/2019 | Nuvolo | Series B | 12M |
| 1/2007 | Calypso Medical | Series D | 42.2M |
| 9/2022 | Kate Farms | Series C | 75M |
| 7/2012 | Agile Therapeutics | Series C | 0 |
| 6/2010 | Agile Therapeutics | Series B | 0 |
| 9/2013 | Xanitos | Venture Round | 0 |
| 2/2009 | Arcxis Biotechnologies | Series B | - |
| 12/2015 | Vidyo | Series E | 15M |
| 6/2010 | Baxano | Series C | 30M |
| 6/2016 | Bluesight | Series C | 20.4M |
| 3/2020 | Ordr | Series B | 6M |
| 3/2022 | Osso VR | Series C | 0 |
| 2/2020 | IntelyCare | Series B | 45M |
| 3/2021 | Evidation Health | Series E | 153M |
| 1/2015 | Bluesight | Series B | 12M |
| 4/2015 | Validic | Series B | 12.5M |
| 6/2020 | Big Health | Series B | 39M |
| 11/2020 | Everytable | Series B | 0 |
| 11/2015 | Vapotherm | Series C | 0 |
| 2/2019 | Health Catalyst | Debt Financing | 0 |
| 1/2014 | Health Catalyst | Series C | 0 |
| 10/2022 | NorthOne | Series B | 0 |
| 2/2008 | Accumetrics | Series D | 0 |
| 6/2022 | Ordr | Series C | 0 |
| 1/2005 | GeneOhm Sciences | Series C | 0 |
| 8/2021 | Genome Medical | Series C | 0 |
| 6/2012 | Astute Medical | Series C | 40.4M |
| 7/2014 | Valeritas | Series D | 45M |
| 7/2019 | Freenome | Series B | 160M |
| 4/2013 | Vapotherm | Series A | 0 |
| 6/2012 | TriVascular | Series D | 60M |
| 1/2023 | NOCD | Series B | 0 |
| 9/2019 | Ginger | Series C | 0 |
| 3/2015 | Health Catalyst | Series D | 0 |
| 2/2008 | Zonare Medical Systems | Equity | 30M |
| 3/2021 | Nuvolo | Series C | 32M |
| 7/2017 | Protenus | Series A | 3M |
| 3/2021 | DexCare | Series A | 0 |
| 6/2023 | DexCare | Series C | 0 |
| 7/2015 | Vapotherm | Series C | 0 |
| 11/2017 | Collective Medical Technologies | Series A | 47.5M |
| 11/2007 | Vapotherm | Series E | 11.3M |
| 11/2013 | TriVascular | Series E | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 8/2008 | Vapotherm | Series F | 20.5M |
| 9/2014 | MetricStream | Private Equity Round | 60M |
| 1/2005 | CHF Solutions | Venture Round | 22.9M |
| 9/2012 | Torax Medical | Series D | 0 |
| 5/2010 | Oxford Immunotec | Series D | 26M |
| 9/2020 | Osso VR | Series A | 14M |
| 3/2013 | Health Catalyst | Series B | 0 |
| 11/2018 | Vesta Healthcare | Series A | 10M |
| 11/2002 | NextWeb | Series D | 1.5M |
| 1/2013 | Nordic | Funding Round | 38.3M |
| 7/2020 | Genome Medical | Series B | 0 |
| 3/2012 | GluMetrics | Venture Round | 13.3M |
| 9/2021 | NOCD | Series B | 0 |
| 6/2021 | Protenus | Series D | 0 |
| 1/2018 | Protenus | Series B | 11M |
| 5/2021 | Groups Recover Together | Series C | 60M |
| 4/2005 | BDNA | Series C | 12.5M |
| 1/2012 | CytoPherx | Series C | 34M |
| 8/2020 | Ginger | Series D | 0 |
| 6/2010 | Predictive Biosciences | Series C | 25M |
| 1/2015 | Kit Check | Series B | 12M |
| 8/2022 | Everytable | Series C | 0 |
| 6/2022 | Ordr | Series C | 0 |
| 4/2022 | IntelyCare | Series C | 0 |
| 3/2022 | Osso VR | Series C | 0 |
| 1/2022 | Big Health | Series C | 0 |
| 9/2021 | NOCD | Series B | 0 |
| 8/2021 | Genome Medical | Series C | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 7/2021 | Osso VR | Series B | 0 |
| 6/2021 | Protenus | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
